LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - Buy
LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...
LifeVantage announces results of third-party cell study of health weight stack
LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer ...
LifeVantage soars after seeing a sales boost from its GLP-1 product
LifeVantage (NASDAQ:LFVN) soared in Wednesday trading after the company updated guidance earlier in the day. For FQ2, LifeVantage (NASDAQ:LFVN) sees revenue of $67.5 million vs. $51.5 million ...
Craig-Hallum bullish on LifeVantage, initiates with a Buy
As previously reported, Craig-Hallum initiated coverage of LifeVantage (LFVN) with a Buy rating and $35 price target Interest in weight loss ...
LifeVantage Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack*
LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...
LifeVantage Shares Rise 30% After 2025 Revenue Outlook Improves
LifeVantage shares soared Wednesday after the company said its financial outlook for 2025 is brighter than previously expected. The health and nutrition company's stock rose 30% to $21.40 in morning ...
manilatimes7d
LifeVantage Announces Preliminary Second Quarter Revenue Results and Raises Fiscal 2025 Revenue Guidance
LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal ...